Equites Radar

SSII · SS Innovations International In

Medical DevicesIndiaAnalyst view: Strong Buy

$3.31

+0.27% last session

End-of-day data · close of 2026-09-11

Bearish0 bullish · 5 bearish technical signals
Consensus: Strong Buy (1.00 from 1 analysts)
To mean target: +112.1%

Market cap

$1B

Enterprise value

$1B

Trailing P/E

Forward P/E

-55.0

Dividend yield

Beta

0.58

Avg volume

0M

Employees

0K

Daily Change %

0.27%

5 Days Change

-5.57%

10 Days Change

-5.57%

30 Days Change

-10.80%

60 Days Change

-15.04%

Month to Day Change

-3.59%

Year to Day Change

-43.31%

Analyst Outlook

Consensus ratingStrong Buy
Recommendation mean (1–5)1.00
Covering analysts1
Mean price target$7.00
Low price target$7.00
Upside to mean target+112.1%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)39.6
50-day MA$3.63
200-day MA$4.41
Price vs 50-day MA-8.8%
Price vs 200-day MA-25.0%
MACD histogram-0.02
Volume vs 3-month avg0.4×
52w low $3.2252w high $9.98

Analyst sentiment over time — SSII

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-06-03

Latest call per bank · past 12 months

Recent rating actions

DateFirmActionRatingPrice target
2026-06-03LUCID CAPITAL MARKETSInitiatesBuy$0.00 $7.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-09-11

  • RSI (14): RSI is 40 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 8.8% below the 50-day MA ($3.63).
  • Price vs 200-day MA: Trading 25.0% below the 200-day MA ($4.41).
  • MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
  • MACD (12,26,9): MACD histogram is negative (-0.02) — short-term momentum is fading.
  • 52-week range: Price is within 10% of the 52-week low ($3.22).

SSII Price Chart

Loading chart for SSII

Fundamentals

Revenue (TTM)$0M
EBITDA$0M
Free cash flow$0M
Operating cash flow$0M
Book value / share$0.27
Net Debt / EBITDA-0.6
WACC8.0%
Revenue growth39.00%
Earnings growth

About SS Innovations International In

SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems. The company also develops NADI – Automated Coronary Anastomotic Connector, a micro stapling device; SSi Multi-Fire Clip Applier, a cartridge-based clip applicator; SSi Robotic Stapler; SSi Maya is an enabling digital platform that compliments the SSI Mantra system and enhances surgical capabilities; SSi Guru is a virtual tele illustration; SSi XR Cognitive Skill Simulator is an extended reality (XR) software platform developed to train and educate surgeons and surgical assistants; SSi MantraM; SSi Mantra Tele Surgeon Console (TSC); and 5mm surgical instruments; SSi Holographic Anatomy, an augmented reality tool; SSi Chitrasa – Advanced DICOM Viewer, an AI enabled application viewer; and SSi Mixed Reality Headset, a medical-grade device. In addition, it offers instrument tips, including forceps, scissors, electrocautery tools, scalpels, and other surgical tools. Further, the company provides accessory products, such as sterile drapes, 3d stereo endoscopes, cannulas, and seals, as well as tele proctoring and telesurgery products. Additionally, it offers installation, repair, maintenance, 24/7 technical support, and proactive health monitoring services. The company sells its products through direct sales organizations and distributor networks. SS Innovations International, Inc. is headquartered in Gurugram, India.

More in Medical Devices

Screen SSII against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.